In addition to anti-tumor responses, immune checkpoint inhibitors have also been associated with long - term
remission in a subset of patients, Gu said.
The cytokines interleukin - 2 (IL - 2) and interferon - alpha cause kidney cancers to shrink in approximately 10 % -20 % of patients, and provide durable
remissions in a subset of these patients.
Not exact matches
Targeted drugs and combination therapies can drive cancer into
remission, as they achieve optimal results
in subsets of patients.